Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
06.02.24
/
50%
€383.95
Target price
06.02.25
€502.09
Performance (%)
2.25%
Price
10.05.24
€392.60
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 2.25%. This prediction currently runs until 06.02.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 5.368% | 5.368% |
iShares Core DAX® | 4.094% | 4.888% |
iShares Nasdaq 100 | 1.424% | -0.445% |
iShares Nikkei 225® | -1.572% | -4.911% |
iShares S&P 500 | 1.822% | 0.776% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Wells Fargo & Company from $500.00 to $540.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat